FDA Inspection
Osteolife Biomedical I LLCOsteolife Biomedical I LLC – FDA Inspection, Feb 14, 2023
Record Details
This FDA Inspection record concerns Osteolife Biomedical I LLC, with an inspection on February 14, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · eef2a42a-0d42-4d5a-a386-6797bcbfc617
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1197358
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 1271.230(a)Validation & approval--established procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Osteolife Biomedical I LLC
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 13, 2026 | Not classified | Florida District Office | Human Cellular, Tissue, and Gene Therapies |
| February 4, 2022 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 28, 2018 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Osteolife Biomedical I LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.